Digital Biomarkers Market Size & Share, by Component (Data Collection Tools, Data Integration Systems); Therapeutic Area (Cardiovascular Diseases, Neurodegenerative Disorders, Sleep & Movement Diseases, Chronic Pain, Gastrointestinal Diseases, Diabetes, Respiratory Conditions); Application (Wellness, Disease Diagnosis, Personalized Medication, Drug Discovery & Development) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3217
  • Published Date: Sep 25, 2023
  • Report Format: PDF, PPT

Global Digital Biomarker Market TOC

  1. An Outline of the Global Digital Biomarker Market
    1. Market Definition
    2. Market Segmentation
    3. Industry Overview
  2. Assumptions & Abbreviations
  3. Research Methodology & Approach
    1. Research Process
    2. Primary Research
      1. Manufacturers
      2. Service Providers 
      3. End Users
    3. Secondary Research
    4. Market Size Estimation
  4. Summary of the Report for Key Decision Makers
  5. Forces of Market Constituents
    1. Factors/drivers impacting the growth of the market
    2. Market trends for better business practices
  6. Key Market Opportunities for Business Growth
  7. Major Roadblocks for the Market Growth
  8. Decarbonization Strategy and Carbon Credit Benefits for Market Players
    1. Global Government Decarbonization Plans/Goals by Each Country under 2015 Agreement Agreed by 200 Countries
    2. Measures taken by Countries to Reduce Carbon Footprints
    3. Carbon Credits and Subsidy Plans/Benefits Rolled out by the Government for Market Players
    4. Effective Ways to Harness Carbon-Credits and Impact on Profit Margins
    5. Demand Impact on the Companies Opting for Carbon Credits
  9. Government Regulation: How They Would aid Business?
  10. Industry Risk Analysis
  11. Global Economic Outlook: Challenges for Global Recovery and its Impact on Global Digital Biomarker Market
    1. Ukraine-Russia crisis
    2. Potential US economic slowdown
  12. Pipeline Analysis
  13. Industry Growth Outlook
  14. Industry Value Chain Analysis
  15. End User Analysis
  16. Competitive Positioning: Strategies to Differentiate a Company From its Competitor
  17. Competitive Model: A Detailed Inside View for Investors
    1. Company Market Share (2022)
    2. Business Profile of Key Enterprise
    3. nQ Medical
      1. ALTOIDA
      2. ActiGraph, LLC
      3. VivoSense
      4. EVOCAL Health GmbH
      5. Koneksa
      6. Cosinuss GmbH
      7. Biofourmis
      8. Lunit Inc.
      9. IMVARIA Inc.
  18. Global Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Component
        1. Data Collection Tools, Market Value (USD Million) and CAGR, 2022-2035F
        2. Mobile Apps, Market Value (USD Million) and CAGR, 2022-2035F
        3. Wearables, Market Value (USD Million) and CAGR, 2022-2035F
        4. Biosensors, Market Value (USD Million) and CAGR, 2022-2035F
        5. Contact-free sensors, Market Value (USD Million) and CAGR, 2022-2035F
        6. Others, Market Value (USD Million) and CAGR, 2022-2035F
        7. Data Integration Systems, Market Value (USD Million) and CAGR, 2022-2035F
      2. Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Therapeutic Area
        1. Cardiovascular Diseases, Market Value (USD Million) and CAGR, 2022-2035F
        2. Neurodegenerative Disorders, Market Value (USD Million) and CAGR, 2022-2035F
          1. Parkinson’s Disease, Market Value (USD Million) and CAGR, 2022-2035F
          2. Multiple Sclerosis, Market Value (USD Million) and CAGR, 2022-2035F
          3. Alzheimer’s Disease, Market Value (USD Million) and CAGR, 2022-2035F
          4. Others, Market Value (USD Million) and CAGR, 2022-2035F
        3. Sleep and Movement Diseases, Market Value (USD Million) and CAGR, 2022-2035F
        4. Chronic Pain, Market Value (USD Million) and CAGR, 2022-2035F
        5. Gastrointestinal Diseases, Market Value (USD Million) and CAGR, 2022-2035F
        6. Diabetes, Market Value (USD Million) and CAGR, 2022-2035F
        7. Respiratory Conditions, Market Value (USD Million) and CAGR, 2022-2035F
        8. Other Diseases, Market Value (USD Million) and CAGR, 2022-2035F
      3. Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Application
        1. Wellness, Market Value (USD Million) and CAGR, 2022-2035F
        2. Disease Diagnosis, Market Value (USD Million) and CAGR, 2022-2035F
        3. Personalized Medication, Market Value (USD Million) and CAGR, 2022-2035F
        4. Drug Discovery and Development, Market Value (USD Million) and CAGR, 2022-2035F
      4. Global Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By End User
        1. Biopharmaceutical Companies & Labs, Market Value (USD Million) and CAGR, 2022-2035F
        2. Healthcare Providers, Market Value (USD Million) and CAGR, 2022-2035F
        3. Others, Market Value (USD Million) and CAGR, 2022-2035F
      5. Global Digital Biomarker Market Segmentation Analysis (2022-2035) By Geography
        1. North America, Market Value (USD Million) and CAGR, 2022-2035F
        2. Europe, Market Value (USD Million) and CAGR, 2022-2035F
        3. Asia Pacific, Market Value (USD Million) and CAGR, 2022-2035F
        4. Latin America, Market Value (USD Million) and CAGR, 2022-2035F
        5. Middle East & Africa, Market Value (USD Million) and CAGR, 2022-2035F
  19. Cross Analysis of Components w.r.t. Application (USD Million), 2022
  20. North America Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Component
        1. Data Collection Tools, Market Value (USD Million) and CAGR, 2022-2035F
        2. Mobile Apps, Market Value (USD Million) and CAGR, 2022-2035F
        3. Wearables, Market Value (USD Million) and CAGR, 2022-2035F
        4. Biosensors, Market Value (USD Million) and CAGR, 2022-2035F
        5. Contact-free sensors, Market Value (USD Million) and CAGR, 2022-2035F
        6. Others, Market Value (USD Million) and CAGR, 2022-2035F
        7. Data Integration Systems, Market Value (USD Million) and CAGR, 2022-2035F
      2. North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Therapeutic Area
        1. Cardiovascular Diseases, Market Value (USD Million) and CAGR, 2022-2035F
        2. Neurodegenerative Disorders, Market Value (USD Million) and CAGR, 2022-2035F
          1. Parkinson’s Disease, Market Value (USD Million) and CAGR, 2022-2035F
          2. Multiple Sclerosis, Market Value (USD Million) and CAGR, 2022-2035F
          3. Alzheimer’s Disease, Market Value (USD Million) and CAGR, 2022-2035F
          4. Others, Market Value (USD Million) and CAGR, 2022-2035F
        3. Sleep and Movement Diseases, Market Value (USD Million) and CAGR, 2022-2035F
        4. Chronic Pain, Market Value (USD Million) and CAGR, 2022-2035F
        5. Gastrointestinal Diseases, Market Value (USD Million) and CAGR, 2022-2035F
        6. Diabetes, Market Value (USD Million) and CAGR, 2022-2035F
        7. Respiratory Conditions, Market Value (USD Million) and CAGR, 2022-2035F
        8. Other Diseases, Market Value (USD Million) and CAGR, 2022-2035F
      3. North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Application
        1. Wellness, Market Value (USD Million) and CAGR, 2022-2035F
        2. Disease Diagnosis, Market Value (USD Million) and CAGR, 2022-2035F
        3. Personalized Medication, Market Value (USD Million) and CAGR, 2022-2035F
        4. Drug Discovery and Development, Market Value (USD Million) and CAGR, 2022-2035F
      4. North America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By End User
        1. Biopharmaceutical Companies & Labs, Market Value (USD Million) and CAGR, 2022-2035F
        2. Healthcare Providers, Market Value (USD Million) and CAGR, 2022-2035F
        3. Others, Market Value (USD Million) and CAGR, 2022-2035F
    4. North America Digital Biomarker Market Segmentation Analysis (2022-2035) By Country
      1. US, Market Value (USD Million) and CAGR, 2022-2035F
      2. Canada, Market Value (USD Million) and CAGR, 2022-2035F
  21. Europe Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. Europe Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Component
      2. Europe Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Therapeutic Area
      3. Europe Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Application
      4. Europe Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By End User
      5. Europe Digital Biomarker Market Segmentation Analysis (2022-2035) By Country
        1. UK, Market Value (USD Million) and CAGR, 2022-2035F
        2. Germany, Market Value (USD Million) and CAGR, 2022-2035F
        3. France, Market Value (USD Million) and CAGR, 2022-2035F
        4. Italy, Market Value (USD Million) and CAGR, 2022-2035F
        5. Spain, Market Value (USD Million) and CAGR, 2022-2035F
        6. Russia, Market Value (USD Million) and CAGR, 2022-2035F
        7. Netherlands, Market Value (USD Million) and CAGR, 2022-2035F
        8. Rest of Europe, Market Value (USD Million) and CAGR, 2022-2035F
  22. Asia Pacific Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. Asia Pacific Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Component
      2. Asia Pacific Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Therapeutic Area
      3. Asia Pacific Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Application
      4. Asia Pacific Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By End User
      5. Asia Pacific Digital Biomarker Market Segmentation Analysis (2022-2035) By Country
        1. China, Market Value (USD Million) and CAGR, 2022-2035F
        2. Japan, Market Value (USD Million) and CAGR, 2022-2035F
        3. India, Market Value (USD Million) and CAGR, 2022-2035F
        4. Australia, Market Value (USD Million) and CAGR, 2022-2035F
        5. South Korea, Market Value (USD Million) and CAGR, 2022-2035F
        6. Singapore, Market Value (USD Million) and CAGR, 2022-2035F
        7. Rest of Asia Pacific, Market Value (USD Million) and CAGR, 2022-2035F
  23. Latin America Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. Latin America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Component
      2. Latin America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Therapeutic Area
      3. Latin America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Application
      4. Latin America Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By End User
      5. Latin America Digital Biomarker Market Segmentation Analysis (2022-2035) By Country
        1. Mexico, Market Value (USD Million) and CAGR, 2022-2035F
        2. Argentina, Market Value (USD Million) and CAGR, 2022-2035F
        3. Brazil, Market Value (USD Million) and CAGR, 2022-2035F
        4. Rest of Latin America, Market Value (USD Million) and CAGR, 2022-2035F
  24. Middle East & Africa Digital Biomarker Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (YoY) Growth Trend Analysis
      1. Middle East & Africa Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Component
      2. Middle East & Africa Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Therapeutic Area
      3. Middle East & Africa Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By Application
      4. Middle East & Africa Digital Biomarker Market Outlook & Projections, Opportunity Assessment by Segment, 2022-2035, By End User
      5. Middle East & Africa Digital Biomarker Market Segmentation Analysis (2022-2035) By Country
        1. GCC, Market Value (USD Million) and CAGR, 2022-2035F
        2. Israel, Market Value (USD Million) and CAGR, 2022-2035F
        3. South Africa, Market Value (USD Million) and CAGR, 2022-2035F
        4. Rest of Middle East & Africa, Market Value (USD Million) and CAGR, 2022-2035F

 


Companies Dominating the Digital Biomarker Landscape

top-features-companies
    • IMVARIA Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • nQ Medical
    • ALTOIDA
    • ActiGraph, LLC.
    • VivoSense
    • EVOCAL Health GmbH
    • Koneksa Health
    • Cosinuss GmbH
    • Biofourmis
    • Lunit Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • June 2023: Koneska Health joined forces with Beacon Biosignals, a biomarker platform engineered in the United States that is designed to speed up clinical trials and facilitate novel medications for patients with neurological and psychiatric diseases, to conduct clinical trials
  • April 2023: ActiGraph announces the collaboration with Precision Digital Health (PDH), a U.S.-based company that provides wearable and biomarker data.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3217
  • Published Date: Sep 25, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increasing number of clinical trials, and the rising burden of cognitive issues and chronic disorders are the major factors driving the market growth.

The market size of digital biomarker is anticipated to attain a CAGR of 32.15% over the forecast period, i.e., 2023 – 2035.

The major players in the market are nQ Medical, ALTOIDA, ActiGraph, LLC., VivoSense, EVOCAL Health GmbH, Koneksa Health, Cosinuss GmbH, Biofourmis, Lunit Inc., and IMVARIA Inc.

The neurogenerative disorder segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying